Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00056589
Status:
COMPLETED
Last Update Posted:
2017-01-11
First Post:
2003-03-18
Brief Title:
Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Congenital FXIII Deficiency |
| Congenital Bleeding Disorder |
Keywords: